MedTrace Logo

Preventive Intervention Against Lymphedema After Breast Cancer Surgery

NCT02518477 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2018-09-14

No results posted yet for this study

Summary

This study will examine whether lymphedema after breast cancer surgery can be reduced. In a randomised controlled design the aim is to investigate whether an early intervention with progressive resistance training and close monitoring of arm swelling can reduce the incidence of lymphedema after breast cancer surgery.

Conditions

  • Breast Neoplasms

Interventions

OTHER

exercise

progressive resistance training

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Herlev Hospital

    collaborator OTHER

  • Ringsted sygehus

    collaborator UNKNOWN

  • Danish Cancer Society

    lead OTHER

Principal Investigators

  • Susanne Oksbjerg Dalton, MD PhD · Danish Cancer Society Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02518477 on ClinicalTrials.gov